182 related articles for article (PubMed ID: 31587105)
21. Cytomegalovirus pre-emptive therapy after hematopoietic stem cell transplantation in the era of real-time quantitative PCR: comparison with recipients of solid organ transplants.
Panagou E; Zakout G; Keshani J; Smith C; Irish D; Mackinnon S; Kottaridis P; Fielding A; Griffiths PD
Transpl Infect Dis; 2016 Jun; 18(3):405-14. PubMed ID: 27061703
[TBL] [Abstract][Full Text] [Related]
22. Allogeneic hematopoietic stem cell transplant recipients and parasitic diseases: A review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections.
Fabiani S; Fortunato S; Petrini M; Bruschi F
Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28128496
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic yield of the cytomegalovirus (CMV) antigenemia assay and clinical features in solid organ transplant recipients and hematopoietic stem cell transplant recipients with CMV pneumonia.
Moon SM; Sung H; Kim MN; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
Transpl Infect Dis; 2012 Apr; 14(2):192-7. PubMed ID: 22260384
[TBL] [Abstract][Full Text] [Related]
24. Characteristics of de novo cancer in liver transplant recipients.
Riis TH; Møller DL; Høgh J; Knudsen AD; Rostved AA; Akdag D; Kirkby N; Lassen U; Rasmussen A; Hillingsø JG; Pommergaard HC
APMIS; 2023 Apr; 131(4):135-141. PubMed ID: 36680559
[TBL] [Abstract][Full Text] [Related]
25. Solid organ transplantation following allogeneic haematopoietic cell transplantation: experience from a referral organ transplantation center and systematic review of literature.
Brockmann JG; Broering DC; Raza SM; Rasheed W; Hashmi SK; Chaudhri N; Nizami IY; Alburaiki JAH; Shagrani MA; Ali T; Aljurf M
Bone Marrow Transplant; 2019 Feb; 54(2):190-203. PubMed ID: 30082851
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" Study.
Choi JK; Cho SY; Yoon SS; Moon JH; Kim SH; Lee JH; Kim JS; Cheong JW; Jang JH; Seo BJ; Kim YJ; Lee HJ; Lee J; Lee JW; Lee DG
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1773-1779. PubMed ID: 28668492
[TBL] [Abstract][Full Text] [Related]
27. [De novo cancer after solid organ transplantation: Epidemiology, prognosis and management].
Guillemin A; Rousseau B; Neuzillet C; Joly C; Boussion H; Grimbert P; Compagnon P; Duvoux C; Tournigand C
Bull Cancer; 2017 Mar; 104(3):245-257. PubMed ID: 28237352
[TBL] [Abstract][Full Text] [Related]
28. Adult patients with respiratory syncytial virus infection: impact of solid organ and hematopoietic stem cell transplantation on outcomes.
Pilie P; Werbel WA; Riddell J; Shu X; Schaubel D; Gregg KS
Transpl Infect Dis; 2015 Aug; 17(4):551-7. PubMed ID: 26059180
[TBL] [Abstract][Full Text] [Related]
29. Predictive implications of albumin and C-reactive protein for progression to pneumonia and poor prognosis in Stenotrophomonas maltophilia bacteremia following allogeneic hematopoietic stem cell transplantation.
Harada K; Sekiya N; Konishi T; Nagata A; Yamada Y; Takezaki T; Kaito S; Kurosawa S; Sakaguchi M; Yasuda S; Sasaki S; Yoshioka K; Watakabe-Inamoto K; Igarashi A; Najima Y; Hagino T; Muto H; Kobayashi T; Doki N; Kakihana K; Sakamaki H; Ohashi K
BMC Infect Dis; 2017 Sep; 17(1):638. PubMed ID: 28938875
[TBL] [Abstract][Full Text] [Related]
30. Second solid cancers after allogeneic hematopoietic stem cell transplantation.
Gallagher G; Forrest DL
Cancer; 2007 Jan; 109(1):84-92. PubMed ID: 17131350
[TBL] [Abstract][Full Text] [Related]
31. The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation.
Webb BJ; Harrington R; Schwartz J; Kammerer J; Spalding J; Lee E; Dodds B; Kaufusi S; Goodman BE; Firth SD; Martin G; Sorensen J; Hoda D
Transpl Infect Dis; 2018 Oct; 20(5):e12961. PubMed ID: 29975816
[TBL] [Abstract][Full Text] [Related]
32. Toxoplasmosis in Transplant Recipients, Europe, 2010-2014.
Robert-Gangneux F; Meroni V; Dupont D; Botterel F; Garcia JMA; Brenier-Pinchart MP; Accoceberry I; Akan H; Abbate I; Boggian K; Bruschi F; Carratalà J; David M; Drgona L; Djurković-Djaković O; Farinas MC; Genco F; Gkrania-Klotsas E; Groll AH; Guy E; Hirzel C; Khanna N; Kurt Ö; Junie LM; Lazzarotto T; Len O; Mueller NJ; Munoz P; Pana ZD; Roilides E; Stajner T; van Delden C; Villena I; Pelloux H; Manuel O
Emerg Infect Dis; 2018 Aug; 24(8):1497-1504. PubMed ID: 30014843
[TBL] [Abstract][Full Text] [Related]
33. Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis.
Shimada K; Yokozawa T; Atsuta Y; Kohno A; Maruyama F; Yano K; Taji H; Kitaori K; Goto S; Iida H; Morishima Y; Kodera Y; Naoe T; Morishita Y
Bone Marrow Transplant; 2005 Jul; 36(2):115-21. PubMed ID: 15908969
[TBL] [Abstract][Full Text] [Related]
34. Characteristics and Outcomes of De Novo Genitourinary Malignancy in Solid Organ Transplant Recipients at the University of Minnesota.
Cleveland B; Gardeck A; Holten M; Jiang S; Jackson S; Pruett T; Warlick C
Transplant Proc; 2023 Nov; 55(9):2027-2034. PubMed ID: 37775402
[TBL] [Abstract][Full Text] [Related]
35. Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark.
Jensen AO; Svaerke C; Farkas D; Pedersen L; Kragballe K; Sørensen HT
Acta Derm Venereol; 2010 Sep; 90(5):474-9. PubMed ID: 20814621
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic cancer among solid organ transplant recipients in the United States.
Tanaka T; Lynch CF; Yu KJ; Morawski BM; Hsieh MC; Alverson G; Austin AA; Zeng Y; Engels EA
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3325-3333. PubMed ID: 35932302
[TBL] [Abstract][Full Text] [Related]
37. Secondary malignancies after hematopoietic stem cell transplantation.
Roziakova L; Bojtarova E; Mistrik M; Mladosievicova B
Neoplasma; 2011; 58(1):1-8. PubMed ID: 21067259
[TBL] [Abstract][Full Text] [Related]
38. Cancer risk and mortality after solid organ transplantation: A population-based 30-year cohort study in Finland.
Friman TK; Jäämaa-Holmberg S; Åberg F; Helanterä I; Halme M; Pentikäinen MO; Nordin A; Lemström KB; Jahnukainen T; Räty R; Salmela B
Int J Cancer; 2022 Jun; 150(11):1779-1791. PubMed ID: 35041762
[TBL] [Abstract][Full Text] [Related]
39. Association of Sirolimus Use With Risk for Skin Cancer in a Mixed-Organ Cohort of Solid-Organ Transplant Recipients With a History of Cancer.
Karia PS; Azzi JR; Heher EC; Hills VM; Schmults CD
JAMA Dermatol; 2016 May; 152(5):533-40. PubMed ID: 26792250
[TBL] [Abstract][Full Text] [Related]
40. Harnessing Mechanisms of Immune Tolerance to Improve Outcomes in Solid Organ Transplantation: A Review.
Slepicka PF; Yazdanifar M; Bertaina A
Front Immunol; 2021; 12():688460. PubMed ID: 34177941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
